IL-27/IL-35 EBI3 Subunit (Dimer), (Heterodimer), (Monomer) Antikörper

Produktnummer ABIN2665152

Dieses Ratte Monoklonal-Antikörper erkennt spezifisch in FACS. Er zeigt eine Reaktivität gegenüber Maus.

Kurzübersicht für IL-27/IL-35 EBI3 Subunit (Dimer), (Heterodimer), (Monomer) Antikörper (ABIN2665152)

Target: IL-27/IL-35 EBI3 Subunit

Reaktivität: Maus

Wirt: Ratte

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: Flow Cytometry (FACS)

Klon: J053B5

Produktdetails

Bindungsspezifität: Dimer, Heterodimer, Monomer

Aufreinigung: The antibody was purified by affinity chromatography.

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: The antibody solution should be stored undiluted between 2°C and 8°C.

Antigendetails

Target: IL-27/IL-35 EBI3 Subunit

Andere Bezeichnung: IL-27/IL-35 EBI3

Hintergrund: EBI3 is an IL-12 p40-related protein that can heterodimerized with IL-12 p35 to form IL-35, or with an IL-12 p35-related protein, p28, to form IL-27. It is produced by antigen-presenting cells such as B cells, monocytes, and dendritic cells (DCs) following stimulation through TLR. It can regulate T cell differentiation and proliferation. Both IL-27 and IL-35 are anti-inflammatory cytokines that are able to inhibit Th17 generation, promote Th1 differentiation, increase cytolytic activity of CD8+ T cells, and impact B cell differentiation and immunoglobulin production. IL-35 is also involved in tumorigenesis and is a promising biomarker for assessing tumor progression and prognosis in clinical settings.